Anthem Biosciences Limited (ANTHEM) Share Analysis
NSE · Healthcare · Healthcare
Anthem Biosciences Limited (NSE: ANTHEM) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400. As of 21 Sep 2026, the share price was ₹928.00, market capitalisation ₹52,306 Cr, P/E 88.2, ROE 22.3%.
Get the AI verdict on ANTHEM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
ANTHEM price and valuation
- Share price
- ₹928.00
- Market cap
- ₹52,306 Cr
- P/E ratio
- 88.2
- P/B ratio
- 17.12
- EPS
- ₹10.25
- Book value per share
- ₹54.20
- Dividend yield
- 0.22%
ANTHEM profitability and growth
- ROE
- 22.3%
- ROCE
- 30.4%
- Debt to equity
- 0.02
- Revenue growth (3 yr)
- 26%
- Revenue growth (5 yr)
- 14%
- Profit growth (3 yr)
- 21%
- Profit growth (5 yr)
- 17%
ANTHEM 52-week range
- 52-week high
- ₹977.55
- 52-week low
- ₹579.15
- Face value
- ₹2.00
ANTHEM shareholding pattern
- Promoters
- 71.42%
- FIIs
- 2.57%
- DIIs
- 13.48%
- Public
- 12.52%
Index membership: NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.